Innate Pharma S.A. (IPHA)
NASDAQ: IPHA · Real-Time Price · USD
1.805
-0.005 (-0.28%)
At close: Jul 2, 2026, 4:00 PM EDT
1.800
-0.005 (-0.28%)
After-hours: Jul 2, 2026, 4:00 PM EDT
Innate Pharma Market Cap
Innate Pharma has a market cap or net worth of $178.6 million as of July 2, 2026. Its market cap has increased by 10.24% in one year.
Market Cap
178.60M
Enterprise Value
165.17M
1-Year Change
10.24%
Ranking
Category
Stock Price
$1.81
Market Cap Chart
Since October 18, 2019, Innate Pharma's market cap has decreased from $480.08M to $178.60M, a decrease of -62.80%. That is a compound annual growth rate of -13.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 3, 2026 | 178.60M | 3.01% |
| Dec 31, 2025 | 173.38M | 4.71% |
| Dec 31, 2024 | 165.58M | -29.08% |
| Dec 29, 2023 | 233.49M | -17.19% |
| Dec 30, 2022 | 281.97M | -29.50% |
| Dec 31, 2021 | 399.94M | 19.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 18, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Oramed Pharmaceuticals | 188.26M |
| Protalix BioTherapeutics | 186.93M |
| OnKure Therapeutics | 185.01M |
| LENZ Therapeutics | 184.68M |
| Equillium | 183.99M |
| Caribou Biosciences | 180.51M |
| Milestone Pharmaceuticals | 179.59M |
| Outlook Therapeutics | 175.25M |